The U.S. Food and Drug Administration has cleared the new version of MIM Software’s mobile imaging app, which is now approved for diagnostic X-ray and ultrasound viewing, the company announced.
The U.S. Food and Drug Administration has cleared the new version of MIM Software’s mobile imaging app, which is now approved for diagnostic X-ray and ultrasound viewing, the company annouced.
Mobile MIM is also cleared for radiation treatment plan review and approval, the company said. Mobile MIM received FDA 510(k) clearance in February 2011, becoming the first diagnostic radiology app approved for viewing images and medical diagnoses based on CT, MRI, and nuclear medical technology.
Jerimy Brockway, software director at MIM, called the addition of viewing X-ray on a handheld device “a milestone for mobile health.” Mobile MIM can display images of more than 25 megapixels.
Mobile MIM is a thick client that brings the data to the device for fast manipulation independent of network performance, according to the company. Device-level hardware encryption provides security for HIPAA compliance, and users can remove data from the device after viewing.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.